A phase I clinical and pharmacokinetic study of Brequinar sodium, DUP 785 (NSC 368390), using a weekly and a biweekly schedule.

Source:http://linkedlifedata.com/resource/pubmed/id/2591433

Download in:

View as

General Info

PMID
2591433